About This Project
Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem completely different from case to case. Medicine that is made as a general "cure all" can not keep up with this disease because of said personalization of cancer. In this experiment I will be testing if Carcinosin, a homeopathic drug, can be modified to become an effective, personalized cancer treatment with minimal cost to make.
Ask the ScientistsJoin The Discussion
What is the context of this research?
Carcinosin is a drug that falls under a subdivision of homeopathy called isopathy. Isopathy modifies the homeopathic principle of “like cures like” to “same cures same”. In other words, a sample of diseased tissue made into a mother tincture and potentialized can cure said disease. Following this rule Carcinosin is made using cancerous tissue or cultures. According to the rules of isopathy, this should provide a drug that proves effective. In medical journals (see lab notes), this is only to be true sometimes. After reading medical journals, reviewing carcinosin, and isopathic principles, it became evident what was missing. Carcinosin does not always work due to variation in each cancers' genes. Following this idea, Carcinosin will be modified to overcome cancer's diversity.
What is the significance of this project?
Cancer has touched many of our lives in one way or another. Friends and family alike are taken by the crippling disease. For those who do survive, they often are swamped by the overwhelming debt of treatment costs. Cancer drugs on average cost about $10,000 per month; some as high as $30,000 a month (“Oncologists Worry About Rising Costs of Cancer Treatment” U.S. News & World Report, July 1, 2015). This does not include the drugs used to offset the side effects of those treatments. This project is done, though, in hopes to provide an effective drug that will cost a fraction of this price. An effective, lower costing drug would both increase the rate of cancer survivals and decrease the amount of debt with which many cancer patients find themselves.
What are the goals of the project?
The ultimate goal of this project is to verify that Carcinosin can be modified to compensate for cancer's uniqueness, thereby consistently and effectively treating cancerous tissue (in the form of cultured cells in this phase of the project).
This will be done by culturing a line of lung cancer, a line of colon cancer, and a line of normal human cells. Cell cultures will be exposed to the modified drug, current market form of Carcinosin (positive control), and DI water (negative control) respectively, in same quantities. One trial will last three days. Multiple trials will be done over the course of a few months with other cultures created from the initial purchased cells, as to allow multiple rounds of trails to be done without more cancer cells to be purchased.
- First in the budget are cell lines which include one lung cancer line, one colon cancer line, and a normal human colon line. Lung and colon cancer both are cancers that are commonly found in America and tend to be less treatable. The normal human colon line is for testing the safety of the drug.
- Second are the materials for growing the cells. These include mediums for growth (and additives that make the medium more like a host body), flasks for culture growth and subculturing, Trypsin-EDTA Solution for subculturing, DMOS for freezing cell lines, and a 96 cell well plate to hold small samples of cells during experiment.
- Lastly are the materials to make the modified drug and the current form of Carcinosin. Glycerin and DI water will be used as the medium for dissolving and potentializing the experimental forms of Carcinosin. Test tubes will be needed both for diluting the drug and storage. The current form of Carcinosin is needed as a positive control.
Meet the Team
I was born in southern California. I am working towards my bachelors degree through MCPHS' Premed program. Through curiosity and compassion I have found my deep interest the medical field. I have taken it upon myself to learn herbalism and homeopathy through reading and practicing it on mild ailments. Also I have a principle that I use when evaluating medicine, when practicing herbalism and homeopathy, and in the possible development of drugs. This principle is as follows: "Medicine is the art of compassion". In other words: medicine should be compassionate towards the patient and the practitioners of medicine should also be compassionate in practicing their trade. This principle sums up how I view and plan to practice medicine.
Throughout the course of this project updates on this project will continually be posted on this website. These updates will be open for everyone, regardless of financial contribution. Publication of results will also be through this webcite.
- $3,386Total Donations
- $116.76Average Donation